Faculty Connection unites clients with the vast pool of thought leaders and experts at the DCRI and at Duke University at large, finding the best match for each particular need. The company is managed by a 5-member board, composed of highly respected individuals in the academic world. Below is a summary of their bios.

	Robert Califf - Dr. Califf is a previous director of the Duke Databank for Cardiovascular Disease, the largest repository of cardiovascular research data in the world. In 1996, he became director of the DCRI, combining his roles at Duke University as a professor of medicine and a leading cardiologist at Duke University Medical Center with his experience as a clinical researcher. He has led some of the most influential cardiology trials of the past decade, including the CAVEAT, GUSTO, and TAMI series of trials. Under his leadership, the DCRI has grown to become the world’s largest academic clinical research organization, having conducted more than 220 studies in more than 60 countries. Dr. Califf is an internationally recognized expert on evidence-based medicine and is the author of more than 650 peer-reviewed publications. He is a fellow and member of the Board of Trustees of the American College of Cardiology and also serves as editor-in-chief of the American Heart Journal. conflict of interest
	Ken Lyles, MD - Dr. Lyles joined the DCRI in 1999, and is a distinguished physician-investigator with more than 20 years of experience in geriatrics. In addition to his role leading all geriatrics research at the DCRI, he is Clinical Director of the Geriatric Research, Education and Clinic Center of the Durham Veterans Affairs Medical Center. Dr. Lyles also directs the VA Medical Center’s Geriatric Fellowship program and serves as a senior fellow of the Center for the Study of Aging and Human Development at Duke University. He is a fellow of the American College of Physicians and the American Geriatrics Society. Dr. Lyles sits on the editorial board for the Society’s journal, as well as the Journal of Geriatric Pharmacotherapy. He is currently a professor of medicine at Duke University.
	Bob Harrington, MD - Dr. Harrington has been head of the DCRI’s Cardiovascular Clinical Trials division since 1999. He has helped design and lead some of the largest cardiology trials of the past several years, including PURSUIT, PARAGON-A, and PARAGON-B. Before becoming a professor of medicine at Duke University Medical Center, Dr. Harrington taught at the University of Massachusetts Medical Center, where he was selected as an Outstanding Medical Educator. He is a fellow of the American College of Cardiology and of the Society for Cardiovascular Angiography and Intervention, as well as an associate editor of the American Heart Journal. He has authored numerous peer-review publications, review articles, book chapters and editorials, and coedited a recent textbook on antiplatelet therapy. conflict of interest
	John McHutchison, MD - Dr. McHutchison joined Duke and the DCRI in 2002 as the head of the DCRI’s Gastroenterology and Hepatology Research division. He is a distinguished GI and liver disease researcher, serving previously as an assistant professor of medicine at the University of Southern California and Medical Director for Liver Transplantation at Scripps Clinic after leaving his native Australia. He has published world-wide in the field of liver diseases, and is the author of numerous articles and book chapters on chronic hepatitis C infection. Dr. McHutchison sits on many advisory committees and editorial boards, including those of the National Institute of Allergy and Infectious Diseases, the University of Melbourne Medical School, the Medical Research Council of the United Kingdom and the journals Hepatology and Viral Hepatitis Review. Dr. McHutchison is a Fellow of the Royal Australian College of Physicians and is a member of several professional organizations including the American Association for the Study of Liver Diseases and the American Gastroenterology Association.
	Kevin Schulman, MD - Dr. Schulman established the Center for Clinical and Genetic Economics within the DCRI in 1999. As the head of this innovative group, he has led groundbreaking quality-of-life and outcomes research. In addition to his role at the DCRI, Dr. Schulman holds a joint appointment at Duke’s Fuqua School of Business and serves as the Director of the School’s Health Sector Management Program (HSM). Under his direction, the HSM program has become the largest such program at a top-tier business school in the country. Dr. Schulman is also Vice-Chairperson for Business Affairs for the Department of Medicine at the Duke University School of Medicine. Dr. Schulman is a professor of business administration at Fuqua and a professor of medicine in the Duke University School of Medicine. He is the author of more than 130 peer-reviewed papers and a recipient of the Alice S. Hersh Young Investigators Award from the Association for Health Services Research. conflict of interest